2011
DOI: 10.3109/13506129.2010.549252
|View full text |Cite
|
Sign up to set email alerts
|

A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases – data from nationwide registries in Finland

Abstract: Risk for amyloidosis in rheumatic diseases is associated with a long-lasting inflammation. To assess possible changes in the incidence of terminal uraemia due to amyloidosis associated with rheumatic diseases on a nationwide basis, we scrutinised the files of the Finnish Registry for Kidney Diseases for patients suffering from amyloidosis associated with rheumatoid arthritis (RA), ankylosing spondylitis (AS) or juvenile idiopathic arthritis (JIA) over the period 1995-2008. The registry has an estimated 97-99% … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0
3

Year Published

2011
2011
2017
2017

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(24 citation statements)
references
References 18 publications
1
18
0
3
Order By: Relevance
“…Thus, better treatments for rheumatoid arthritis and disorders of pyrin-associated pathways (e.g., familial Mediterranean fever and related disorders) utilizing biologics targeting either cytokines or their receptors have markedly reduced the incidence of AA as a consequence of these conditions. [122][123][124] The apparent uniqueness of the process of amyloidogenesis related to TTR deposition, in which the monomer aggregation precursor concentration is increased in the absence of increased synthesis or aberrant processing (J. Kelly, this volume), has allowed TTR-specific approaches to therapy and possible prophylaxis. Since 1990, the standard therapy for this disease has been liver transplantation.…”
Section: The Application Of Molecular Insights To Therapy (1975 Onward)mentioning
confidence: 98%
“…Thus, better treatments for rheumatoid arthritis and disorders of pyrin-associated pathways (e.g., familial Mediterranean fever and related disorders) utilizing biologics targeting either cytokines or their receptors have markedly reduced the incidence of AA as a consequence of these conditions. [122][123][124] The apparent uniqueness of the process of amyloidogenesis related to TTR deposition, in which the monomer aggregation precursor concentration is increased in the absence of increased synthesis or aberrant processing (J. Kelly, this volume), has allowed TTR-specific approaches to therapy and possible prophylaxis. Since 1990, the standard therapy for this disease has been liver transplantation.…”
Section: The Application Of Molecular Insights To Therapy (1975 Onward)mentioning
confidence: 98%
“…In a Finnish report from 1985, over a period of 10 years, approximately 9% of 1,000 individuals with RA died from renal amyloidosis (50). With the increasingly active and successful treatment of chronic autoimmune diseases, including RA, with modern drugs such as tumor necrosis factor (TNF) receptor and interleukin (IL)-6 blockers (51), AA amyloidosis has become rare in the western world (52,53). In some parts of the world, a high incidence of AA amyloidosis persists (54), indicating that AA amyloidosis is unlikely to disappear altogether.…”
Section: Aa Amyloidosismentioning
confidence: 99%
“…Chronic infections, such as tuberculosis and osteomyelitis, have long been the most common causes of AA amyloidosis while today they are more relevant only in certain developing countries [4]. The incidence of AA amyloidosis in patients with rheumatoid arthritis and ankylosing spondylitis is also decreasing as a result of earlier and more aggressive treatment with disease modifying antirheumatic drugs and biologic agents [5].…”
Section: Discussionmentioning
confidence: 99%